Supply Chain Council of European Union | Scceu.org
Distribution

Zetia Wholesalers Denied Class Cert. In Generics-Delay Suit

by scceu0297

By Bryan Koenig (April 14, 2022, 7:37 PM EDT) — A group of wholesalers accusing Merck and Glenmark Pharmaceuticals of a scheme to delay a generic cholesterol drug are unlikely to force a settlement on the companies after a Virginia federal judge refused to certify a proposed class to pursue the claims.

On the second go-around for class action status after the Fourth Circuit erased a previous certification, U.S. District Judge Rebecca Beach Smith on Wednesday delivered an important win for the companies after finding 35 Zetia buyers aren’t enough and individual participation isn’t sufficiently “impractical” to justify certification.

By wholly adopting the recommendation against certification from U.S. Magistrate Judge Douglas…

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Related posts

Distribution ERP Software Market Overview, High Growth Opportunities, Segmentation, Trends By 2022-2028

scceu

Amid Jury Win, 5-Hour Energy Faces Unfair Pricing Claims

scceu

Talks with Guyana ongoing, says energy minister

scceu